Menu
Search
|

Menu

Close
X

Endo International PLC ENDP.OQ (NASDAQ Stock Exchange Global Select Market)

6.88 USD
+0.00 (+0.00%)
As of Feb 16
chart
Previous Close 6.88
Open 6.84
Volume 999,184
3m Avg Volume 1,483,284
Today’s High 7.05
Today’s Low 6.79
52 Week High 14.45
52 Week Low 5.77
Shares Outstanding (mil) 223.29
Market Capitalization (mil) 1,915.85
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.59 Mean rating from 22 analysts

KEY STATS

Revenue (mm, USD)
FY17
2,700
FY16
4,010
FY15
3,269
EPS (USD)
FY17
-4.307
FY16
-14.466
FY15
-1.463
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
0.47
5.77
Price to Book (MRQ)
vs sector
2.37
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
1,024.02
16.52
LT Debt to Equity (MRQ)
vs sector
1,019.80
12.22
Return on Investment (TTM)
vs sector
-35.02
14.43
Return on Equity (TTM)
vs sector
-124.07
16.13

EXECUTIVE LEADERSHIP

Roger Kimmel
Independent Chairman of the Board, Since 2007
Salary: --
Bonus: --
Paul Campanelli
President, Chief Executive Officer, Director, Since 2016
Salary: $987,038.00
Bonus: $712,500.00
Blaise Coleman
Chief Financial Officer, Executive Vice President, Since 2016
Salary: $349,308.00
Bonus: $216,563.00
Antonio Pera
President - Par Pharmaceutical, Since 2016
Salary: --
Bonus: --
Terrance Coughlin
Chief Operating Officer, Executive Vice President, Since 2016
Salary: $556,280.00
Bonus: $315,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Minerva House, Simmonscourt Road
DUBLIN     00000

Phone: +3531.2682000
Site: www.endo.com

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.

SPONSORED STORIES